341 related articles for article (PubMed ID: 10572233)
1. [Aromatase inhibitors].
Feutrie ML; Bonneterre J
Bull Cancer; 1999 Oct; 86(10):821-7. PubMed ID: 10572233
[TBL] [Abstract][Full Text] [Related]
2. New aromatase inhibitors for the treatment of advanced breast cancer in postmenopausal women.
de Jong PC; Blijham GH
Neth J Med; 1999 Aug; 55(2):50-8. PubMed ID: 10474272
[TBL] [Abstract][Full Text] [Related]
3. [Aromatase inhibitors: a review of clinical trials].
Kerbrat P; Lefeuvre C
Bull Cancer; 2000 Dec; 87 Spec No():31-39. PubMed ID: 11250606
[TBL] [Abstract][Full Text] [Related]
4. Use of aromatase inhibitors in breast carcinoma.
Santen RJ; Harvey HA
Endocr Relat Cancer; 1999 Mar; 6(1):75-92. PubMed ID: 10732791
[TBL] [Abstract][Full Text] [Related]
5. Use of aromatase inhibitors in postmenopausal women with advanced breast cancer.
Roseman BJ; Buzdar AU; Singletary SE
J Surg Oncol; 1997 Nov; 66(3):215-20. PubMed ID: 9369969
[TBL] [Abstract][Full Text] [Related]
6. Steroidal aromatase inhibitors in elderly patients.
Bajetta E; Zilembo N; Bichisao E; Pozzi P; Toffolatti L
Crit Rev Oncol Hematol; 2000 Feb; 33(2):137-42. PubMed ID: 10737375
[TBL] [Abstract][Full Text] [Related]
7. [Preclinical evaluation of aromatase inhibitors antitumor activity].
Auvray P; Bichat F; Genne P
Bull Cancer; 2000 Dec; 87 Spec No():7-22. PubMed ID: 11250604
[TBL] [Abstract][Full Text] [Related]
8. Emerging role of aromatase inhibitors in the treatment of breast cancer.
Harvey HA
Oncology (Williston Park); 1998 Mar; 12(3 Suppl 5):32-5. PubMed ID: 9556789
[TBL] [Abstract][Full Text] [Related]
9. The third-generation non-steroidal aromatase inhibitors: a review of their clinical benefits in the second-line hormonal treatment of advanced breast cancer.
Hamilton A; Piccart M
Ann Oncol; 1999 Apr; 10(4):377-84. PubMed ID: 10370778
[TBL] [Abstract][Full Text] [Related]
10. Nonsteroidal and steroidal aromatase inhibitors in breast cancer.
Hamilton A; Volm M
Oncology (Williston Park); 2001 Aug; 15(8):965-72; discussion 972, 977-9. PubMed ID: 11548977
[TBL] [Abstract][Full Text] [Related]
11. A summary of second-line randomized studies of aromatase inhibitors.
Buzdar AU
J Steroid Biochem Mol Biol; 2001 Dec; 79(1-5):109-14. PubMed ID: 11850214
[TBL] [Abstract][Full Text] [Related]
12. A comparison of the efficacy of aromatase inhibitors in second-line treatment of metastatic breast cancer.
Rose C
Am J Clin Oncol; 2003 Aug; 26(4):S9-16. PubMed ID: 12902872
[TBL] [Abstract][Full Text] [Related]
13. Aromatase inhibitors and their use in the sequential setting.
Coombes RC; Harper-Wynne C; Dowsett M
Endocr Relat Cancer; 1999 Jun; 6(2):259-63. PubMed ID: 10731118
[TBL] [Abstract][Full Text] [Related]
14. Aromatase inhibitors come of age.
Dowsett M
Ann Oncol; 1997 Jul; 8(7):631-2. PubMed ID: 9296213
[No Abstract] [Full Text] [Related]
15. Theoretical considerations for the ideal aromatase inhibitor.
Dowsett M
Breast Cancer Res Treat; 1998; 49 Suppl 1():S39-44; discussion S73-7. PubMed ID: 9797016
[TBL] [Abstract][Full Text] [Related]
16. Survival with aromatase inhibitors and inactivators versus standard hormonal therapy in advanced breast cancer: meta-analysis.
Mauri D; Pavlidis N; Polyzos NP; Ioannidis JP
J Natl Cancer Inst; 2006 Sep; 98(18):1285-91. PubMed ID: 16985247
[TBL] [Abstract][Full Text] [Related]
17. A roundtable discussion of aromatase inhibitors as therapy for breast cancer.
Allred DC; Baum M; Buzdar AU; Carlson RW; Dowsett M; Elledge RM; Gradishar WJ; Grana G; Howell A; Mamounas EP
Breast J; 2003; 9(3):213-22. PubMed ID: 12752630
[TBL] [Abstract][Full Text] [Related]
18. Approval summary: letrozole in the treatment of postmenopausal women with advanced breast cancer.
Cohen MH; Johnson JR; Li N; Chen G; Pazdur R
Clin Cancer Res; 2002 Mar; 8(3):665-9. PubMed ID: 11895893
[TBL] [Abstract][Full Text] [Related]
19. Applicability of the intratumor aromatase preclinical model to predict clinical trial results with endocrine therapy.
Brodie AH; Mouridsen HT
Am J Clin Oncol; 2003 Aug; 26(4):S17-26. PubMed ID: 12902873
[TBL] [Abstract][Full Text] [Related]
20. New generation aromatase inhibitors--from the advanced to the adjuvant setting.
Buzdar AU
Breast Cancer Res Treat; 2002 Oct; 75 Suppl 1():S13-7; discussion S33-5. PubMed ID: 12353818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
